Body distribution of azidothymidine bound to nanoparticles after oral administration

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 44, Issue 2, 1997, Pages 127-132

  Lobenberg R ^a   Araujo, L ^a   Kreuter, J ^a,b  

^a Biocenter Johann Wolfgang Goethe U   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

AZT; Body distribution; Drug targeting; Macrophages; Nanoparticles

Indexed keywords

CYANOACRYLATE DERIVATIVE; DOCUSATE SODIUM; DRUG CARRIER; MONOMER; NANOPARTICLE; NUCLEOSIDE ANALOG; SURFACTANT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COLLOID; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG TARGETING; FEMALE; MACROPHAGE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RETICULOENDOTHELIAL SYSTEM;

EID: 0344352474     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00078-7     Document Type: Article

References (32)

1. S. Roy, M.A. Wainberg, Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS), J. Leukocyte Biol. 43 (1989) 91-97.
2. M.S. Meltzer, D.R. Skillman, D.L. Hoover, B.D. Hanson, J.A. Turpin, D.C. Kalter, H.E. Gendelman, Macrophages and the human immunodeficiency virus, Immunol. Today 11 (1990) 217-223.
3. R. Löbenberg, J. Kreuter, Macrophage-targeting of AZT: a promising strategy for AIDS therapy, AIDS Res. Hum. Retroviruses 12 (1996) 1709-1715.
4. J. Kreuter, U. Täuber, V. Illi, Distribution and elimination of poly(methyl-2-[14C]methacrylate) nanoparticle radioactivity after injection in rats and mice, J. Pharm. Sci. 68 (1979) 1443-1447.
5. L.D. S.S. Ilium, C.G. Wilson, N.W. Thomas, M. Frier, J.G. Hardy, Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape, Int. J. Pharm. 12 (1982) 135-146.
6. M. Nefzger, J. Kreuter, R. Voges, E. Liehl, R. Czok, Distribution and elimination of polymethyl-methacrylate nanoparticles after peroral administration to rats, J. Pharm. Sci. 73 (1984) 1309-1311.
7. A.T. Florence, A.M. Hillery, N. Hussain, P.U. Jani, Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence, J. Drug Targeting 3 (1995) 65-70.
8. G.M. Hodges, E.A. Carr, R.A. Hazzard, C. O'Reilly, K.E. Carr, A commentary on morphological and quantitative aspects of microparticle translocation across the gastrointestinal mucosa, J. Drug Targeting 3 (1995) 57-60.
9. P.U. Jani, D.E. McCarthy, A.T. Florence, Nanosphere and microsphere uptake via Peyeŕs patches: observation of the rate of uptake in the rat after single oral dose, Int. J. Pharm. 86 (1992) 239-246.
10. A.M. Hillery, P.U. Jani, A.T. Florence. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles, J. Drug Targeting 2 (1994) 151-156.
11. J. Kreuter, V. Müller, K. Munz, Quantitative and microautora-diographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles, Int. J. Pharm. 55 (1989) 39-45.
12. C. Damgé, M. Aprahamian, G. Balboni, A. Hoeltzel, V. Andrieu, J.P. Devissaguet, Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug, Int. J. Pharm. 36 (1987) 121-125.
13. J. McCullough, G. Hodges, G. Dickson, A. Yarwood, K. Carr, A morphological and microanalytical investigation onto the uptake of particulate iron across the gastrointestinal tract of rats. J. Submicrosc. Cytol. Pathol. 27 (1995) 119-124.
14. D. O'Hagan, Intestinal translocation of participates: implication for drug and antigen delivery, Adv. Drug Deliv. Rev. 5 (1990) 265-285.
15. G. McLeod, S. Hammer, Zidovudine: five years later, Ann. Intern. Med. 117 (1992) 487-501.
16. A. Bender, V. Schäfer, A. Steffan, C. Royer, J. Kreuter, H. Rübsamen-Waigmann, H.V. von Briesen, Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles, Res. Virol. 145 (1994) 215-220.
17. P. Schölmerich, E. Mutschler, G. Thews, Saquinavir, Protease-hemmer als neue Kombinationspartner, Arzneimitteltherapie 14 (1996) 58-60.
18. A. Bender, H. von Briesen, J. Kreuter, I.B. Ducan, H. Rübsamen-Waigmann, Efficiency of nanoparticles as carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro, Antimicrob. Agents Chemother. 40 (1996) 1467-1471.
19. P. Maincent, R.L. Verge, P. Sado, P. Couvreur, J.P. Devissaguet, Disposition kinetics and oral bioavailability of Vincamine loaded polyalkylcyanoacrylate nanoparticles, J. Pharm. Sci. 75 (1986) 955-958.
20. P.H. Beck, J. Kreuter, W.E.G. Müller, W. Schatten, Improved peroral delivery of avarol with polybutylcyanoacrylate nanoparticles, Eur. J. Biopharm. 40 (1994) 134-137.
21. C. Pimienta, V. Lenaerts, C. Cadieux, P. Raymond, J. Jushasz, M.-A. Simard, C. Jolicoeur, Mucoadhesion of hydroxypropylmethacrylate nanoparticles to rat intestinal ileal segments in vitro, Pharm. Res. 7 (1990) 49-53.
22. D. Scherer, J.R. Robison, J. Kreuter, Influence of enzymes on the stability of polybutylcyanoacrylate nanoparticles, Int. J. Pharm. 101 (1994) 165-168.
23. A.M. Le Ray, M. Vert, J.C. Gautier, J.P. Benoit, Fate of [14C]poly(DL-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice, Int. J. Pharm. 106 (1994) 201-211.
24. P. Jani, W. Halbert, J. Langride, A.T. Florence, The uptake and translocation of latex nanospheres and microspheres after oral administration to rats, J. Pharm. Pharmacol. 41 (1989) 809-812.
25. P. Jani, G.W. Halbert, J. Langridge, A.T. Florence, Nanoparticle uptake by rat gastrointestinal mucosa: quantification and particle size dependency, J. Pharm. Pharmacol. 42 (1990) 821-826.
26. J.H. Eldridge, C.J. Hammond, J.A. Meulbroek, J.K. Staas, R.M. Gilley, T.R. Tice, Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches, J. Control. Release 11 (1990) 205-214.
27. J.-C. Leroux, R.M. Cozens, J.L. Roesel, B. Galli, F. Kubel, E. Doelker, R. Gurny, Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice, J. Pharm. Sci. 84 (1995) 1387-1391.
28. J. Kreuter, S.N. Mills, S.S. Davies, C.G. Wilson, Polybutylcyanoacrylate nanoparticles for the delivery of [75Se]norcholesterol, Int. J. Pharm. 16 (1983) 105-113.
29. P. Maincent, P. Thouvenot, C. Amicabile, M. Huffman, J. Kreuter, P. Couvreur, J.P. Devissaguet, Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats, Pharm. Res. 9 (1992) 1534-1539.
30. G. Christofinis, L. Papadaki, Q. Sattentau, R.B. Ferns, R. Tedder, HIV replicates in cultured human brain cells, AIDS 1 (1987) 229-234.
31. K. Dykstra, A. Arya, D. Arriola, P. Bungay, P. Morrion, R.L. Dedrick, Microdialysis study of Zidovudine (AZT) transport on rat brain, J. Pharmacol. Exp. Ther. 27 (1993) 1227-1236.
32. J.E.F. Reynolds (Ed.), Antiviral agents, Martindale, vol. 30, Pharmaceutical Press, London, 1993, pp. 560-563.